Cloetta's Nomination Committee for the AGM 2027

By Cision
Cloetta AB

Cloetta, Northern Europe's leading confectionery company, announces that the Nomination Committee has now been appointed ahead of the Annual General Meeting on 13 April 2027. In accordance with the decision of the Annual General Meeting, Cloetta AB's Nomination Committee shall consist of at least four and at most six members. 

The Nomination Committee consists of the following members: 

Lars Schedin, Chairman, appointed by AB Malfors Promotor
Magdalena Kettis, appointed by Nordea Funds
Lena Lundin, appointed by Ulla Håkanson
Morten Falkenberg, appointed by the Board of Cloetta AB

The Nomination Committee shall prepare recommendations to be submitted to the Annual General Meeting 2027 regarding the election of Board members, the Chairman of the Board and auditors, as well as fees for the Board of Directors and remuneration for the auditors. The Nomination Committee’s proposal regarding the Board members is published through a separate press release at a later date. All other proposals will be included in the notice of the 2027 Annual General Meeting.

Cloetta’s 2027 Annual General Meeting will be held on Tuesday, 13 April 2027 in Stockholm, Sweden.

Shareholders are welcome to send proposals to the Nomination Committee ahead of the 2027 Annual General Meeting no later than 31 January 2027, by e-mail to the Chairman of the Nomination Committee: nominationcommittee (@) cloetta.com.
 

Investor and media contact
Laura Lindholm, Director, Communications & Investor Relations
+46 705 11 26 22

Cloetta’s press and investor desk

+46 766 96 59 40

ir (@) cloetta.com
press.group (@) cloetta.com
sustainability (@) cloetta.com

For more information from Cloetta and press images, visit www.cloetta.com/en/media/
 

https://news.cision.com/cloetta-ab/r/cloetta-s-nomination-committee-for-the-agm-2027%2Cc4401599

Press release as PDF

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.